Skip to main content
SpringerLink
Log in

The routine injection of dextranomer/hyaluronan into contralateral, nonrefluxing ureters in patients with unilateral vesicoureteral reflux (VUR) is not justified,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Routh JC, Vandersteen DR, Ashley RA, Inman BA, Reinberg Y, Wolpert JJ, Kramer SA, Husmann DA.Routine contralateral deflux injection in patients with unilateral reflux: increased cost without increased efficacy? Journal of Urology 177 (Suppl.): 172-173, No. 4, Apr 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The routine injection of dextranomer/hyaluronan into contralateral, nonrefluxing ureters in patients with unilateral vesicoureteral reflux (VUR) is not justified,. Pharmacoecon. Outcomes News 529, 7 (2007). https://doi.org/10.2165/00151234-200705290-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705290-00019

Keywords

Search

Navigation